Hsbc Holdings PLC Amgen Inc Call Options Transaction History

Hsbc Holdings PLC

$168 Billion
Q3 2024

Call Options

24 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 12, 2024	SELL	$262.75 - $319.31 $3.84 Million - $4.66 Million	-14,600 Reduced 23.32%	48,000 $15 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $5.03 Million - $6.07 Million	18,700 Added 42.6%	62,600 $17.8 Million
Q4 2023 Feb 12, 2024	BUY	$255.7 - $288.46 $8.51 Million - $9.61 Million	33,300 Added 314.15%	43,900 $12.6 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $1.31 Million - $1.55 Million	-6,100 Reduced 36.53%	10,600 $2.35 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $6.01 Million - $7.32 Million	-26,600 Reduced 61.43%	16,700 $4.04 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $526,769 - $669,323	-2,300 Reduced 5.04%	43,300 $11.4 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $718,272 - $810,080	3,200 Added 7.55%	45,600 $10.4 Million
Q2 2022 Aug 11, 2022	BUY	$230.71 - $256.74 $3.25 Million - $3.62 Million	14,100 Added 49.82%	42,400 $10.3 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $4.45 Million - $4.92 Million	20,300 Added 253.75%	28,300 $6.91 Million
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $298,320 - $341,400	1,500 Added 23.08%	8,000 $1.8 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $3.44 Million - $4.01 Million	-15,500 Reduced 70.45%	6,500 $1.62 Million
Q4 2020 Feb 25, 2021	BUY	$216.38 - $257.67 $2.88 Million - $3.43 Million	13,300 Added 152.87%	22,000 $5.06 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $7.65 Million - $8.51 Million	-32,600 Reduced 78.93%	8,700 $2.21 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $7.98 Million - $10.6 Million	-43,800 Reduced 51.47%	41,300 $8.41 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $3.31 Million - $4.26 Million	17,500 Added 25.89%	85,100 $20.4 Million
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $2.12 Million - $2.48 Million	12,700 Added 23.13%	67,600 $12.5 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $13.7 Million - $15.4 Million	-75,700 Reduced 57.96%	54,900 $10.4 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $3.68 Million - $4.29 Million	20,600 Added 18.73%	130,600 $25.4 Million
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $2.26 Million - $2.55 Million	12,200 Added 12.47%	110,000 $22.8 Million
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $6.89 Million - $7.74 Million	-41,500 Reduced 29.79%	97,800 $18.1 Million
Q1 2018 May 11, 2018	BUY	$169.43 - $198.0 $22.8 Million - $26.6 Million	134,500 Added 2802.08%	139,300 $23.7 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $37.5 Million - $41.9 Million	-222,100 Reduced 97.88%	4,800 $835,000
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $6.61 Million - $7.54 Million	39,500 Added 21.08%	226,900 $42.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	187,400	187,400 $32.3 Million

Others Institutions Holding AMGN

# of Institutions

3,126

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $142B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account